Table 2. AChE and BuChE inhibition and antioxidant activity of synthesized compounds (3a–3o).
| Compounds | AChE IC50 ± SE (μM) | BuChE IC50 ± SE (μM) | Selectivity ratio | % Free radical scavenging, mean ± SE (μM) | |
|---|---|---|---|---|---|
| 50 μM | 100 μM | ||||
| 3a | 1.920 ± 0.065 | 0.865 ± 0.038 | 2.22 | 09.42 ± 0.291 | 19.43 ± 0.421 |
| 3b | 1.634 ± 0.066 | 0.0285 ± 0.019 | 57.33 | 17.24 ± 0.521 | 32.83 ± 0.139 |
| 3c | 2.145 ± 0.095 | 1.871 ± 0.074 | 1.15 | 15.41 ± 0.422 | 28.23 ± 0.420 |
| 3d | 3.905 ± 0.091 | 0.575 ± 0.054 | 6.79 | 20.59 ± 0.318 | 42.41 ± 0.281 |
| 3e | 8.633 ± 0.082 | 3.829 ± 0.065 | 2.25 | 16.35 ± 0.522 | 33.13 ± 0.138 |
| 3f | 27.27 ± 0.010 | 20.983 ± 0.069 | 1.30 | 14.42 ± 0.136 | 29.52 ± 0.361 |
| 3g | 14.73 ± 0.010 | 19.78 ± 0.010 | 0.74 | 17.28 ± 0.428 | 31.51 ± 0.411 |
| 3h | 2.341 ± 0.082 | 6.842 ± 0.042 | 0.34 | 15.19 ± 0.291 | 32.11 ± 0.220 |
| 3i | 15.37 ± 0.010 | 18.84 ± 0.013 | 0.82 | 07.31 ± 0.428 | 12.45 ± 0.310 |
| 3j | 8.397 ± 0.060 | 4.252 ± 0.029 | 1.97 | 16.62 ± 0.252 | 33.24 ± 0.194 |
| 3k | 15.033 ± 0.012 | 19.831 ± 0.042 | 0.76 | 05.13 ± 0.503 | 09.69 ± 0.352 |
| 3l | 1.928 ± 0.010 | 2.731 ± 0.042 | 0.71 | 07.52 ± 0.218 | 15.55 ± 0.153 |
| 3m | 2.554 ± 0.012 | 0.952 ± 0.052 | 2.68 | 05.92 ± 0.422 | 11.53 ± 0.213 |
| 3n | 6.042 ± 0.018 | 1.053 ± 0.026 | 5.74 | 12.34 ± 0.248 | 27.52 ± 0.520 |
| 3o | 16.74 ± 0.068 | 25.93 ± 0.033 | 0.65 | 14.83 ± 0.310 | 29.42 ± 0.351 |
| Donepezil | 2.019 ± 0.068 | 17.38 ± 0.028 | 0.12 | — | — |
| Tacrine | 29.84 ± 0.04 | 28.49 ± 0.02 | — | — | — |
| Ascorbic acid | — | — | — | 45.83 ± 1.030 | 82.01 ± 1.42 |